These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20401660)

  • 41. Macrophages contribute to cellular but not humoral mechanisms of acute rejection in rat renal allografts.
    Ma FY; Woodman N; Mulley WR; Kanellis J; Nikolic-Paterson DJ
    Transplantation; 2013 Dec; 96(11):949-57. PubMed ID: 24056626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of xanthine oxidoreductase in experimental acute renal-allograft rejection.
    Sun K; Kiss E; Bedke J; Stojanovic T; Li Y; Gwinner W; Gröne HJ
    Transplantation; 2004 Jun; 77(11):1683-92. PubMed ID: 15201667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection.
    Kakuta Y; Okumi M; Miyagawa S; Tsutahara K; Abe T; Yazawa K; Matsunami K; Otsuka H; Takahara S; Nonomura N
    Transplantation; 2012 Jan; 93(1):24-31. PubMed ID: 22124337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of Spleen Tyrosine Kinase Reduces Renal Allograft Injury in a Rat Model of Acute Antibody-Mediated Rejection in Sensitized Recipients.
    Ramessur Chandran S; Han Y; Tesch GH; Di Paolo J; Mulley WR; Kanellis J; Ma FY; Nikolic-Paterson DJ
    Transplantation; 2017 Aug; 101(8):e240-e248. PubMed ID: 28594748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft.
    Noris M; Azzollini N; Pezzotta A; Mister M; Benigni A; Marchetti G; Gagliardini E; Perico N; Remuzzi G
    J Am Soc Nephrol; 2001 Sep; 12(9):1937-1946. PubMed ID: 11518788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Up-regulation of macrophage migration inhibitory factor in acute renal allograft rejection in the rat.
    Brown FG; Nikolic-Paterson DJ; Metz C; Bucala R; Atkins RC; Lan HY
    Clin Exp Immunol; 1999 Nov; 118(2):329-36. PubMed ID: 10540199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection.
    Dai E; Liu LY; Wang H; McIvor D; Sun YM; Macaulay C; King E; Munuswamy-Ramanujam G; Bartee MY; Williams J; Davids J; Charo I; McFadden G; Esko JD; Lucas AR
    PLoS One; 2010 May; 5(5):e10510. PubMed ID: 20463901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Infections and reduced functioning kidney mass induce chronic rejection in rat kidney allografts.
    Heemann UW; Azuma H; Tullius SG; Schmid C; Philipp T; Tilney NL
    Clin Nephrol; 1996 Jul; 46(1):34-8. PubMed ID: 8832148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression.
    Yilmaz S; Koskinen PK; Kallio E; Bruggeman CA; Häyry PJ; Lemström KB
    Kidney Int; 1996 Aug; 50(2):526-37. PubMed ID: 8840282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pivotal Advance: Up-regulation of acetylcholine synthesis and paracrine cholinergic signaling in intravascular transplant leukocytes during rejection of rat renal allografts.
    Hecker A; Mikulski Z; Lips KS; Pfeil U; Zakrzewicz A; Wilker S; Hartmann P; Padberg W; Wessler I; Kummer W; Grau V
    J Leukoc Biol; 2009 Jul; 86(1):13-22. PubMed ID: 19201987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.
    Ichikawa N; Demetris AJ; Starzl TE; Ye Q; Okuda T; Chun HJ; Liu K; Kim YM; Murase N
    Liver Transpl; 2000 Nov; 6(6):686-702. PubMed ID: 11084053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histological analysis of late renal allografts of antidonor antibody positive patients with C4d deposits in peritubular capillaries.
    Aita K; Yamaguchi Y; Shimizu T; Horita S; Furusawa M; Tanabe K; Fuchinoue S; Toma H
    Clin Transplant; 2004; 18 Suppl 11():7-12. PubMed ID: 15191366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist.
    Braun C; Conzelmann T; Vetter S; Schaub M; Back WE; Yard B; Kirchengast M; Tullius SG; Schnülle P; van der Woude FJ; Rohmeiss P
    Transplantation; 1999 Sep; 68(6):739-46. PubMed ID: 10515373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glomerular capillary pressures in long-surviving rat renal allografts.
    Kingma I; Chea R; Davidoff A; Benediktsson H; Paul LC
    Transplantation; 1993 Jul; 56(1):53-60. PubMed ID: 8333067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
    Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
    Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo microscopic assessment of hepatic microcirculation during liver allograft rejection in the rat.
    Kawano K; Bowers JL; Kruskal JB; Clouse ME
    Transplantation; 1995 May; 59(9):1241-8. PubMed ID: 7762055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
    J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Macrophage-derived interleukin-18 in experimental renal allograft rejection.
    Wyburn K; Wu H; Yin J; Jose M; Eris J; Chadban S
    Nephrol Dial Transplant; 2005 Apr; 20(4):699-706. PubMed ID: 15716294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eukaryotic expression of the broad-spectrum chemokine receptor antagonist vMIP-II and its effects on T-cell function in vitro and in vivo.
    Rubant S; Ludwig RJ; Pfeffer J; Schulze-Johann P; Kaufmann R; Pfeilschifter JM; Boehncke WH; Radeke HH
    Exp Dermatol; 2006 Aug; 15(8):634-42. PubMed ID: 16842602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Desmopressin improves intestinal functional capillary density and decreases leukocyte activation in experimental endotoxemia.
    Wafa K; Lehmann C; Wagner L; Drzymulski I; Wegner A; Pavlovic D
    Microvasc Res; 2015 Jan; 97():98-104. PubMed ID: 24035754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.